Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Cancer metastasis is a primary driver of mortality, responsible for over 90% of cancer-related deaths.
• Effective early detection and prevention strategies for metastasis are crucial for improving patient survival rates.
• Identifying novel biomarkers and therapeutic targets is essential for advancing cancer treatment.

Purpose of the Study:

• To review sialyltransferases and neuraminidases as potential therapeutic targets for various cancers.
• To compile existing experimental and in silico data on these enzymes in cancer.
• To guide researchers in identifying and developing targeted cancer therapies.

Main Methods:

• Literature review of experimental studies on sialyltransferases and neuraminidases in cancer.
• In silico analysis of enzyme roles in cancer progression.
• Compilation of data on existing drugs targeting these enzymes.

Main Results:

• Sialyltransferases and neuraminidases are implicated in the progression of common and rare cancers.
• These enzymes represent promising targets for novel anti-cancer therapies.
• Existing drugs targeting these enzymes offer a basis for further drug development.

Conclusions:

• Targeting sialyltransferases and neuraminidases holds significant potential for treating diverse cancers.
• This review provides a valuable resource for researchers developing targeted cancer therapies.
• Further investigation into these enzymes could lead to improved cancer prevention and treatment strategies.